Scientists take bone samples to unlock osteoporosis Drug's secrets
NCT ID NCT05688969
Summary
This study aims to understand how the osteoporosis medication romosozumab affects bone-building cells over time. Researchers will take small bone samples from 16 postmenopausal women before they start the drug, and then again either a few weeks or several months later. The goal is to see how the drug's effects on bone cells change during early and later stages of treatment, which could help doctors use it more effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS, POSTMENOPAUSAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mass General Brigham
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.